piritrexim has been researched along with Cancer of the Urinary Tract in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreicer, R; Graham, D; Manola, J; Roth, BJ; Wilding, G | 1 |
| Carducci, MA; Hussain, MH; Lassiter, LK; Petrylak, DP; Stadler, WM; Tummala, MK | 1 |
| de Wit, R; Kaye, SB; Roberts, JT; Scott, J; Stoter, G; Verweij, J | 1 |
3 trial(s) available for piritrexim and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Protocols; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Pyrimidines; United States; Urologic Neoplasms; Urothelium | 2002 |
Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Folic Acid Antagonists; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Urologic Neoplasms | 2008 |
Oral piritrexim, an effective treatment for metastatic urothelial cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Methotrexate; Middle Aged; Pyrimidines; Urologic Neoplasms | 1993 |